Low Adiponectin Levels Are Associated With Atherogenic Dyslipidemia and Lipid-Rich Plaque in Nondiabetic Coronary Arteries
Open Access
- 1 May 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (5) , 989-994
Abstract
OBJECTIVE—The purpose of this study was to determine whether an association exists between adiponectin and plaque composition in human coronary arteries. RESEARCH DESIGN AND METHODS—Adiponectin is an adipocyte-derived protein with antiatherogenic and insulin-sensitizing properties. To date, the relationship between adiponectin and plaque composition is unknown. Fasting blood samples were collected from 185 patients undergoing coronary angiography and intravascular ultrasound (IVUS). Plaque composition was categorized as fibrous, fibrofatty, necrotic core, or dense calcium and further classified as IVUS-derived adaptive or pathological intimal thickening, fibroatheroma, fibrocalcific, or thin cap fibroatheroma. RESULTS—Adiponectin correlated with normalized plaque volume (r = −0.16, P = 0.025) and atheroma lipid content as measured by normalized fibrofatty volume (r = −0.19, P = 0.009). Low adiponectin levels were associated with IVUS-derived pathological intimal thickening (r = −0.18, P = 0.01). With increasing quartiles (Q) of adiponectin, the normalized volume of fibrofatty plaque decreased (P = 0.03), which was driven by reductions in the nondiabetic cohort (Q1 44.2 mm3; Q2 28.2 mm3; Q3 24.7 mm3; and Q4 23.4 mm3; P = 0.01). No similar association was present in diabetic patients. Low adiponectin levels were also associated with IVUS-derived pathological intimal thickening in nondiabetic (r = −0.20, P = 0.03) but not diabetic patients. CONCLUSIONS—Low adiponectin levels are associated with atherogenic lipoproteins (elevated triglycerides, small dense LDL cholesterol, and low HDL cholesterol), increased plaque volume, lipid-rich plaque, and IVUS-derived pathological intimal thickening in the total cohort that was driven by the nondiabetic population, suggesting an antiatherogenic role in the early stages of lesion development.Keywords
This publication has 32 references indexed in Scilit:
- Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest painEuropean Heart Journal, 2006
- Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo StudyAmerican Journal of Epidemiology, 2006
- Adiponectin and Mortality in Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Adiponectin and Coronary Heart DiseaseCirculation, 2006
- Serum Adiponectin Levels Are an Independent Predictor of the Extent of Coronary Artery Disease in MenJACC, 2006
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin SensitivityJournal of Biological Chemistry, 2004
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Lessons From Sudden Coronary DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Intravascular ultrasound imaging: In vitro validation and pathologic correlationJACC, 1990